Elias J Jeyarajah

This inventor holds 12 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignees: Liposcience, Inc., Lipscience, Inc.. Active years: 2003-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elias J Jeyarajah. Retrieved from https://idiyas.com/inventor/elias-j-jeyarajah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 12 (Patent Applications = 4)

% Patents Active = 100.0

CIPO Patents = 3

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 4.8

ph-index = 4

Forward Citations = 85(Granted Patents)

Company Filing History:

Years Active: 2003-2023

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11782002 - NMR quantification of TMAO (2023-10-10),

2. 11156685 - NMR analyzers for clinical evaluation of biosamples (2021-10-26),

3. 10613044 - NMR quantification of TMAO (2020-04-07),

4. 10365339 - NMR analyzers for clinical evaluation of biosamples (2019-07-30),

5. 9689942 - Quantitative NMR clinical analyzers with automatic NMR temperature sensitivity compensation that accommodate large ambient operational temperature ranges (2017-06-27),

6. 9541620 - NMR quantification of TMAO (2017-01-10),

7. 9535144 - NMR quantification of TMAO (2017-01-03),

8. 9494666 - NMR measurement of clinically relevant ionized biosample constituents such as ionized calcium and/or magnesium (2016-11-15),

9. 8704521 - NMR analyzers for clinical evaluation of biosamples (2014-04-22),

10. 8013602 - NMR clinical analyzers and related methods, systems, modules and computer program products for clinical evaluation of biosamples (2011-09-06),

11. 7243030 - Methods, systems and computer programs for deconvolving the spectral contribution of chemical constituents with overlapping signals (2007-07-10),

12. 6617167 - Method of determining presence and concentration of lipoprotein X in blood plasma and serum (2003-09-09),

Title: *Elias J Jeyarajah: Innovator in NMR Technology*

Introduction

Elias J Jeyarajah is a distinguished inventor based in Raleigh, NC, with an impressive portfolio of 12 patents. His contributions to the field of nuclear magnetic resonance (NMR) and biomedical analysis have significantly advanced our understanding of key biomarkers and clinical evaluation methods.

Latest Patents

Among his notable innovations, Elias has developed methodologies for NMR quantification of trimethylamine-N-oxide (TMAO). This patent involves a specific peak region in the proton NMR spectrum, allowing for the accurate determination of TMAO levels in various biosamples, including human serum and urine. His research indicates normal biologic ranges for these samples, contributing to clinical diagnostics. Additionally, he has developed clinical NMR analyzers that automatically monitor and adjust parameters to maintain optimal operational ranges. These analyzers can be set up as a network system across multiple clinical sites, enhancing their usability in medical environments.

Career Highlights

Elias J Jeyarajah has worked with reputable companies, including Liposcience, Inc. and LipScience, Inc., where he has leveraged his expertise to drive innovation in clinical NMR technology. His contributions have paved the way for advancements in how biosamples are analyzed and understood, making a significant impact on the biomedical field.

Collaborations

Throughout his career, Elias has collaborated with esteemed colleagues such as James D Otvos and Steven P Matyus. These partnerships have fostered a dynamic exchange of ideas and have been instrumental in the success of his innovations.

Conclusion

Elias J Jeyarajah stands out as a pivotal figure in the realm of NMR technology and biomedical research. His ongoing commitment to innovation, along with his collaborative spirit, positions him as a leading inventor whose work continues to influence the future of clinical laboratory practices.

Profile summary based on public USPTO records.